Clinical trial
Safety and Efficacy of PEG-Encapsulated Islet Allografts Implanted in Type I…
NCT00260234 · Novocell, Industry · Terminated
Key facts
| NCT number | NCT00260234 |
|---|---|
| Title | Safety and Efficacy of PEG-Encapsulated Islet Allografts Implanted in Type I Diabetic Recipients |
| Official title | A Single-Center Phase I/II Study Of Peg-Encapsulated Islet Allografts Implanted In Patients With Type I Diabetes |
| Lead sponsor | Novocell, Industry |
| Collaborators | Diabetes & Glandular Disease Research Associates, P.A., San Antonio, TX CHRISTUS Health |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 1 |
| Intervention type | Biological |
| Interventions | Allogeneic Cultured Islet Cells (human), Encapsulated |
| Enrollment | 12 |
| Start date | Nov 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Dec 1, 2005 |
| Last update posted | Sep 9, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: